Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

USP8 mutations in corticotroph adenomas determine a distinct gene expression profile irrespective of functional tumour status.

Bujko M, Kober P, Boresowicz J, Rusetska N, Paziewska A, Dabrowska M, Piascik A, Pekul M, Zielinski G, Kunicki J, Bonicki W, Ostrowski J, Siedlecki JA, Maksymowicz M.

Eur J Endocrinol. 2019 Oct 1. pii: EJE-19-0194.R2. doi: 10.1530/EJE-19-0194. [Epub ahead of print]

PMID:
31581124
2.

Intradiploic epidermoid cyst of the temporal and occipital bone with intracranial extension.

Dąbrowski P, Kidziński R, Frankowska E, Górski R, Bujko M.

Neurol Neurochir Pol. 2018 Nov - Dec;52(6):756-758. doi: 10.1016/j.pjnns.2018.09.004. Epub 2018 Sep 26. No abstract available.

PMID:
30287078
3.

Telomere length and TERT abnormalities in pituitary adenomas.

Boresowicz J, Kober P, Rusetska N, Maksymowicz M, Goryca K, Kunicki J, Bonicki W, Bujko M.

Neuro Endocrinol Lett. 2018 Mar;39(1):49-55.

PMID:
29803207
4.

DNA methylation profiling in nonfunctioning pituitary adenomas.

Kober P, Boresowicz J, Rusetska N, Maksymowicz M, Goryca K, Kunicki J, Bonicki W, Siedlecki JA, Bujko M.

Mol Cell Endocrinol. 2018 Sep 15;473:194-204. doi: 10.1016/j.mce.2018.01.020. Epub 2018 Feb 1.

PMID:
29410024
5.

Comment on "Identification of Differentially Expressed Genes in Pituitary Adenomas by Integrating Analysis of Microarray Data".

Bujko M.

Int J Endocrinol. 2017;2017:2023530. doi: 10.1155/2017/2023530. Epub 2017 Oct 25. No abstract available.

6.

Downregulation of PTPRH (Sap-1) in colorectal tumors.

Bujko M, Kober P, Statkiewicz M, Mikula M, Grecka E, Rusetska N, Ligaj M, Ostrowski J, Siedlecki JA.

Int J Oncol. 2017 Sep;51(3):841-850. doi: 10.3892/ijo.2017.4068. Epub 2017 Jul 5.

PMID:
28713969
7.

Mutational Analysis of Recurrent Meningioma Progressing From Atypical to Rhabdoid Subtype.

Bujko M, Machnicki MM, Grecka E, Rusetska N, Matyja E, Kober P, Mandat T, Rydzanicz M, Płoski R, Krajewski R, Bonicki W, Stokłosa T, Siedlecki JA.

World Neurosurg. 2017 Jan;97:754.e1-754.e6. doi: 10.1016/j.wneu.2016.10.047. Epub 2016 Oct 15.

PMID:
27756662
8.

Aberrant DNA methylation of alternative promoter of DLC1 isoform 1 in meningiomas.

Bujko M, Kober P, Rusetska N, Wakuła M, Goryca K, Grecka E, Matyja E, Neska J, Mandat T, Bonicki W, Siedlecki JA.

J Neurooncol. 2016 Dec;130(3):473-484. Epub 2016 Sep 10.

9.

Targeted Bisulfite Sequencing-Based Analysis of MGMT Promoter Methylation in Meningiomas.

Bujko M, Kober P.

Asian Pac J Cancer Prev. 2016;17(5):2727-8. No abstract available.

10.

Lenalidomide potentiates CD4+CD25+Treg-related suppression of lymphoma B-cell proliferation.

Grygorowicz MA, Borycka IS, Nowak E, Paszkiewicz-Kozik E, Rymkiewicz G, Błachnio K, Biernacka M, Bujko M, Walewski J, Markowicz S.

Clin Exp Med. 2017 May;17(2):193-207. doi: 10.1007/s10238-016-0411-8. Epub 2016 Mar 10.

PMID:
26961690
11.

Human regulatory T cells suppress proliferation of B lymphoma cells.

Grygorowicz MA, Biernacka M, Bujko M, Nowak E, Rymkiewicz G, Paszkiewicz-Kozik E, Borycka IS, Bystydzienski Z, Walewski J, Markowicz S.

Leuk Lymphoma. 2016 Aug;57(8):1903-20. doi: 10.3109/10428194.2015.1121260. Epub 2016 Jan 12.

PMID:
26758248
12.

Microsatellite instability analysis in pituitary adenomas.

Bujko M, Kober P, Zbijewska J, Kunicki J, Bonicki W.

Neuro Endocrinol Lett. 2015;36(5):511-4.

PMID:
26707053
13.

Expression changes of cell-cell adhesion-related genes in colorectal tumors.

Bujko M, Kober P, Mikula M, Ligaj M, Ostrowski J, Siedlecki JA.

Oncol Lett. 2015 Jun;9(6):2463-2470. Epub 2015 Apr 8.

14.

Epigenetic-Mediated Downregulation of μ-Protocadherin in Colorectal Tumours.

Bujko M, Kober P, Statkiewicz M, Mikula M, Ligaj M, Zwierzchowski L, Ostrowski J, Siedlecki JA.

Gastroenterol Res Pract. 2015;2015:317093. doi: 10.1155/2015/317093. Epub 2015 Apr 20.

15.

Validating candidate reference genes for qRT-PCR-based gene expression analysis in nonfunctioning pituitary adenomas.

Bujko M, Rusetska N, Mikula M.

Pituitary. 2016 Feb;19(1):110-2. doi: 10.1007/s11102-015-0656-3. No abstract available.

PMID:
25893614
16.

Headache as a manifestation of intracranial aneurysm in autosomal dominant polycystic kidney disease.

Niemczyk M, Niemczyk S, Bujko M, Pączek L.

Neurol Neurochir Pol. 2015;49(2):126-8. doi: 10.1016/j.pjnns.2015.02.002. Epub 2015 Feb 27.

PMID:
25890928
17.

Promoter methylation and expression levels of selected hematopoietic genes in pediatric B-cell acute lymphoblastic leukemia.

Musialik E, Bujko M, Kober P, Wypych A, Gawle-Krawczyk K, Matysiak M, Siedlecki JA.

Blood Res. 2015 Mar;50(1):26-32. doi: 10.5045/br.2015.50.1.26. Epub 2015 Mar 24.

18.

Regulation of the expression of claudin 23 by the enhancer of zeste 2 polycomb group protein in colorectal cancer.

Maryan N, Statkiewicz M, Mikula M, Goryca K, Paziewska A, Strzałkowska A, Dabrowska M, Bujko M, Ostrowski J.

Mol Med Rep. 2015 Jul;12(1):728-36. doi: 10.3892/mmr.2015.3378. Epub 2015 Feb 19.

PMID:
25695204
19.

Promoter DNA methylation and expression levels of HOXA4, HOXA5 and MEIS1 in acute myeloid leukemia.

Musialik E, Bujko M, Kober P, Grygorowicz MA, Libura M, Przestrzelska M, Juszczyński P, Borg K, Florek I, Jakóbczyk M, Siedlecki JA.

Mol Med Rep. 2015 May;11(5):3948-54. doi: 10.3892/mmr.2015.3196. Epub 2015 Jan 13.

PMID:
25585874
20.

Blood pressure and intracranial aneurysms in autosomal dominant polycystic kidney disease.

Niemczyk M, Pilecki T, Gradzik M, Bujko M, Niemczyk S, Pączek L.

Kidney Blood Press Res. 2014;39(6):630-5. doi: 10.1159/000368475. Epub 2014 Dec 15.

21.

Histone H3 lysine 27 acetylation is altered in colon cancer.

Karczmarski J, Rubel T, Paziewska A, Mikula M, Bujko M, Kober P, Dadlez M, Ostrowski J.

Clin Proteomics. 2014 Jun 3;11(1):24. doi: 10.1186/1559-0275-11-24. eCollection 2014.

22.

EGFR, PIK3CA, KRAS and BRAF mutations in meningiomas.

Bujko M, Kober P, Tysarowski A, Matyja E, Mandat T, Bonicki W, Siedlecki JA.

Oncol Lett. 2014 Jun;7(6):2019-2022. Epub 2014 Apr 7.

23.

Comparison of promoter DNA methylation and expression levels of genes encoding CCAAT/enhancer binding proteins in AML patients.

Musialik E, Bujko M, Kober P, Grygorowicz MA, Libura M, Przestrzelska M, Juszczyński P, Borg K, Florek I, Jakóbczyk M, Baranowska A, Siedlecki JA.

Leuk Res. 2014 Jul;38(7):850-6. doi: 10.1016/j.leukres.2014.04.013. Epub 2014 May 9.

PMID:
24878001
24.

Repetitive genomic elements and overall DNA methylation changes in acute myeloid and childhood B-cell lymphoblastic leukemia patients.

Bujko M, Musialik E, Olbromski R, Przestrzelska M, Libura M, Pastwińska A, Juszczyński P, Zwierzchowski L, Baranowski P, Siedlecki JA.

Int J Hematol. 2014 Jul;100(1):79-87. doi: 10.1007/s12185-014-1592-0. Epub 2014 May 20.

PMID:
24841671
25.

TET2 Promoter DNA Methylation and Expression Analysis in Pediatric B-cell Acute Lymphoblastic Leukemia.

Musialik E, Bujko M, Wypych A, Matysiak M, Siedlecki JA.

Hematol Rep. 2014 Mar 28;6(1):5333. doi: 10.4081/hr.2014.5333. eCollection 2014 Jan 29.

26.

Target volume for postoperative radiotherapy in non-small cell lung cancer: results from a prospective trial.

Kępka L, Bujko K, Bujko M, Matecka-Nowak M, Salata A, Janowski H, Rogowska D, Cieślak-Żerańska E, Komosińska K, Zawadzka A.

Radiother Oncol. 2013 Jul;108(1):61-5. doi: 10.1016/j.radonc.2013.05.023. Epub 2013 Jun 18.

PMID:
23791302
27.

Neoadjuvant treatment for unresectable rectal cancer: an interim analysis of a multicentre randomized study.

Bujko K, Nasierowska-Guttmejer A, Wyrwicz L, Malinowska M, Krynski J, Kosakowska E, Rutkowski A, Pietrzak L, Kepka L, Radziszewski J, Olszyna-Serementa M, Bujko M, Danek A, Kryj M, Wydmanski J, Zegarski W, Markiewicz W, Lesniak T, Zygulski I, Porzuczek-Zuziak D, Bebenek M, Maciejczyk A, Polkowski W, Czeremszynska B, Cieslak-Zeranska E, Toczko Z, Radkowski A, Kolodziejski L, Szczepkowski M, Majewski A, Jankowski M; Polish Colorectal Study Group.

Radiother Oncol. 2013 May;107(2):171-7. doi: 10.1016/j.radonc.2013.03.001. Epub 2013 Apr 13.

28.

Intracranial aneurysms in autosomal dominant polycystic kidney disease.

Niemczyk M, Gradzik M, Niemczyk S, Bujko M, Gołębiowski M, Pączek L.

AJNR Am J Neuroradiol. 2013 Aug;34(8):1556-9. doi: 10.3174/ajnr.A3456. Epub 2013 Feb 28.

29.

The promoter methylation and expression of the O6-methylguanine-DNA methyltransferase gene in uterine sarcoma and carcinosarcoma.

Bujko M, Kowalewska M, Danska-Bidzinska A, Bakula-Zalewska E, Siedecki JA, Bidzinski M.

Oncol Lett. 2012 Sep;4(3):551-555. Epub 2012 Jun 22.

30.

Estimation of groin recurrence risk in patients with squamous cell vulvar carcinoma by the assessment of marker gene expression in the lymph nodes.

Kowalewska M, Radziszewski J, Goryca K, Bujko M, Oczko-Wojciechowska M, Jarzab M, Siedlecki JA, Bidzinski M.

BMC Cancer. 2012 Jun 6;12:223. doi: 10.1186/1471-2407-12-223.

31.

High frequency of allelic loss at the BRCA1 locus in ovarian cancers: clinicopathologic and molecular associations.

Rzepecka IK, Szafron L, Stys A, Bujko M, Plisiecka-Halasa J, Madry R, Osuch B, Markowska J, Bidzinski M, Kupryjanczyk J.

Cancer Genet. 2012 Mar;205(3):94-100. doi: 10.1016/j.cancergen.2011.12.005.

PMID:
22469508
32.

Lack of microsatellite instability in squamous cell vulvar carcinoma.

Bujko M, Kowalewska M, Zub R, Radziszewski J, Bidzinski M, Siedlecki JA.

Acta Obstet Gynecol Scand. 2012 Mar;91(3):391-4. doi: 10.1111/j.1600-0412.2011.01330.x. Epub 2012 Jan 19.

PMID:
22122671
33.

Point: short-course radiation therapy is preferable in the neoadjuvant treatment of rectal cancer.

Bujko K, Bujko M.

Semin Radiat Oncol. 2011 Jul;21(3):220-7. doi: 10.1016/j.semradonc.2011.02.008. Review.

PMID:
21645867
34.

Methyl-CpG binding column-based identification of nine genes hypermethylated in colorectal cancer.

Kober P, Bujko M, Olędzki J, Tysarowski A, Siedlecki JA.

Mol Carcinog. 2011 Nov;50(11):846-56. doi: 10.1002/mc.20763. Epub 2011 Mar 22.

PMID:
21438024
35.

Adjuvant chemotherapy for rectal cancer.

Bujko K, Glynne-Jones R, Bujko M.

Ann Oncol. 2010 Dec;21(12):2443. doi: 10.1093/annonc/mdq616. No abstract available.

PMID:
21098619
36.

External quality assessment for the determination of diphtheria antitoxin in human serum.

Di Giovine P, Pinto A, Olander RM, Sesardic D, Stickings P, Berbers G, Neal S, Efstratiou A, Paberza R, Dauksiene S, Bujko M, Detcheva A, Joks U, Levent B, von Hunolstein C.

Clin Vaccine Immunol. 2010 Aug;17(8):1282-90. doi: 10.1128/CVI.00096-10. Epub 2010 Jul 7.

37.

Prognostic value of IDH1 mutations identified with PCR-RFLP assay in glioblastoma patients.

Bujko M, Kober P, Matyja E, Nauman P, Dyttus-Cebulok K, Czeremszyńska B, Bonicki W, Siedlecki JA.

Mol Diagn Ther. 2010 Jun 1;14(3):163-9. doi: 10.2165/11537170-000000000-00000.

PMID:
20560678
38.
39.

[Impact of vaginal and cervical colonisation/infection on preterm delivery].

Mijović G, Lukić G, Jokmanović N, Crnogorac S, Kuljić-Kapulica N, Gajić M, Kulauzov M, Bujko M.

Vojnosanit Pregl. 2008 Apr;65(4):273-80. Serbian.

PMID:
18499947
40.

Adjuvant chemotherapy for rectal cancer.

Bujko K, Bujko M.

Lancet. 2008 May 3;371(9623):1502-3; author reply 1503. doi: 10.1016/S0140-6736(08)60650-9. No abstract available.

PMID:
18456096
41.

CHFR gene is neither mutated nor hypermethylated in ovarian cancer.

Ludwig AH, Bujko M, Bidzinski M, Kupryjańczyk J.

Cancer Detect Prev. 2007;31(3):257-61. Epub 2007 Jul 30.

PMID:
17673375
42.

Clinical target volume for rectal cancer: in regard to Roels et al. (Int J Radiat Oncol Biol Phys 2006;65:1129-1142).

Bujko K, Bujko M, Pietrzak L.

Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):313. No abstract available.

PMID:
17448884
43.

Colposcopic and cytologic findings among women with abnormal vaginal flora.

Georgijević AV, Sisović JR, Djukić SV, Bujko MJ.

J Low Genit Tract Dis. 2002 Jul;6(3):155-61.

PMID:
17051015
44.

[Metabolism of amino acids in fetuses with cytomegalovirus infection and growth retardation].

Ljubić A, Sulović V, Svetković M, Novakov A, Bujko M, Kokai Dj, Vukolić D.

Glas Srp Akad Nauka Med. 2002;(47):83-8. Serbian.

PMID:
16078443
45.

[Antenatal homeostasis of insulin and glucose in the fetus with cytomegalovirus infection].

Ljubić A, Sulović V, Svetković M, Novakov A, Bujko M, Kokai Dj, Vukolić D.

Glas Srp Akad Nauka Med. 2002;(47):77-82. Serbian.

PMID:
16078442
46.

[Bacterial vaginosis. Epidemiology and risk factors].

Georgijević A, Cjukić-Ivancević S, Bujko M.

Srp Arh Celok Lek. 2000 Jan-Feb;128(1-2):29-33. Serbian.

PMID:
10916461
47.

[Importance of disposable medical materials and instruments in the prevention of intrahospital infections].

Sbutega-Milosević G, Slepĕvić V, Marmut Z, Bujko M.

Vojnosanit Pregl. 2000 Jan-Feb;57(1):55-8. Serbian.

PMID:
10838958
48.

Essential and nonessential amino acids in appropriate and small for gestational age fetuses with congenital cytomegalovirus infection.

Ljubić A, Cvetković M, Sulović V, Novakov A, Kokai D, Bujko M, Jovanović T, Vukolić D.

Clin Exp Obstet Gynecol. 1997;24(4):206-8.

PMID:
9478320
49.

How congenital cytomegalovirus infection changes insulin and glucose homeostasis in affected fetuses.

Ljubić A, Cvetković M, Sulović V, Bujko M, Jovanović T, Novakov A.

Clin Exp Obstet Gynecol. 1997;24(3):149-51.

PMID:
9478302
50.

[T lymphocytes, non-malignant and premalignant changes in the planocellular epithelium of the uterine cervix].

Kesić V, Sulović V, Bujko M, Dotlić R.

Jugosl Ginekol Perinatol. 1991 Jan-Apr;31(1-2):3-5. Croatian.

PMID:
1875718

Supplemental Content

Support Center